Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

Sponsor
Momentum Data
Study ID
NCT03823794
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
0 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • No intervention — OTHER
    Observational analysis of usual care only

Study Details

Atopic dermatitis (AD), commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used. Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently.

Key Dates

Start date
Feb 1, 2019
Status verified
Jan 2025
Primary completion
Nov 4, 2020
Completion
Nov 4, 2020

Study Design

Enrollment
148,166 participants (actual)

Arms

  • Arm: Active atopic dermatitis
    People fulfilling the diagnostic criteria for active atopic dermatitis during the calendar year 2018, and meeting the inclusion criteria and registered with one of the study practices for one or more years during the study period.

Primary Outcome Measure

Prescription Rates for Atopic Dermatitis Related Treatments: Emollients and Soap Substitutes [ Time Frame: Jan - Dec 2018 inclusive ]

Related Studies